Literature DB >> 332270

Factor V inhibitor and bullous pemphigoid.

K Bryning, J Leslie.   

Abstract

Mesh:

Substances:

Year:  1977        PMID: 332270      PMCID: PMC1631875          DOI: 10.1136/bmj.2.6088.677

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  Proceedings: A high titre circulating inhibitor of human factor V: clinical, biochemical and immunological features and its treatment by plasmapheresis.

Authors:  C S Grace; P Wolf
Journal:  Thromb Diath Haemorrh       Date:  1975-09-30

2.  Massive hemorrhage associated with circulating antibodies to factor V.

Authors:  C A Onuora; J Lindenbaum; H L Nossel
Journal:  Am J Med Sci       Date:  1973-05       Impact factor: 2.378

3.  Observations on a factor-V inhibitor.

Authors:  E B Crowell
Journal:  Br J Haematol       Date:  1975-03       Impact factor: 6.998

  3 in total
  4 in total

Review 1.  Acquired factor V inhibitors: a systematic review.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2011-05       Impact factor: 2.300

Review 2.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Isolation and study of an acquired inhibitor of human coagulation factor V.

Authors:  M E Nesheim; W L Nichols; T L Cole; J G Houston; R B Schenk; K G Mann; E J Bowie
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

4.  Rapid elimination of a high-titer spontaneous factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppression.

Authors:  B Tribl; P Knöbl; K Derfler; S Kapiotis; G Aspöck; U Jäger; W Hörl; K Lechner
Journal:  Ann Hematol       Date:  1995-10       Impact factor: 3.673

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.